국내 사람유두종바이러스백신 접종 후 자발적 이상반응 보고사례의 Brighton Collaboration 기준 활용 가능성 연구
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Myo-Song | - |
dc.contributor.author | You, Seung-Hun | - |
dc.contributor.author | Park, Hye Min | - |
dc.contributor.author | Lee, Min-Taek | - |
dc.contributor.author | Kang, Ye-Jin | - |
dc.contributor.author | Koo, Hyunji | - |
dc.contributor.author | Jung, Sun-Young | - |
dc.date.available | 2020-07-30T02:20:13Z | - |
dc.date.issued | 2020 | - |
dc.identifier.issn | 1226-6051 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/42498 | - |
dc.description.abstract | Objective: To describe patterns of spontaneous reporting on adverse events following immunization (AEFIs) using the human papilloma virus (HPV) vaccine according to the Brighton Collaboration (BC) criteria. Methods: We used the Korea Adverse Event Reporting System (KAERS) database including vaccinations between 2008 and 2017. To apply BC criteria, we classified 58 BC AEFIs into World Health Organization Adverse Reaction Terminology (WHO-ART) codes. We applied MedDRA standard medical queries that were pre-defined as five BC AEFIs. Terminology mapping between MedDRA and WHO-ART terms was performed by three researchers. Descriptive statistics of individual case safety reports were analyzed according to BC applicability. Disproportionality analyses were performed on each BC AEFI and each preferred AEFI term according to the case-noncase approach; reporting odds ratio (ROR) and 95% confidence intervals (CI) were calculated. Results: Among the 30,266 reports of vaccinations between 2008 and 2017, 2,845 reports included the HPV vaccine. Of these reports, 1,511 (53.1%) included at least one BC AEFI. Reports from physicians or manufacturers included more BC AEFIs than from other reporters. Injection site reactions and fever were frequently reported in BC AEFIs; spontaneous abortion and ectopic pregnancy (ROR, 14.29 [95% CI, 4.30-47.49]) and vasculitic peripheral neuropathy (ROR, 8.57 [95% CI, 2.61-28.10]) showed the highest ROR. Among non-BC AEFIs, dizziness or myalgia were frequently reported; exposure during pregnancy (ROR, 23.95 [95% CI, 16.27-35.25]) and inappropriate schedule of administration (ROR, 22.89 [95% CI, 16.74-31.31]) showed the highest ROR. Conclusion: BC criteria would be applicable for labeled AEFIs, whereas analyzing non-BC AEFIs would be useful for detecting unlabeled AEFIs. | - |
dc.format.extent | 12 | - |
dc.language | 한국어 | - |
dc.language.iso | KOR | - |
dc.publisher | 한국임상약학회 | - |
dc.title | 국내 사람유두종바이러스백신 접종 후 자발적 이상반응 보고사례의 Brighton Collaboration 기준 활용 가능성 연구 | - |
dc.title.alternative | Patterns of Spontaneous Adverse Events Reporting on Human Papillomavirus Vaccines according to the Applicability of Brighton Collaboration Criteria in Korea from 2008 to 2017 | - |
dc.type | Article | - |
dc.identifier.doi | 10.24304/kjcp.2020.30.1.19 | - |
dc.identifier.bibliographicCitation | 한국임상약학회지, v.30, no.1, pp 19 - 30 | - |
dc.identifier.kciid | ART002572180 | - |
dc.description.isOpenAccess | N | - |
dc.citation.endPage | 30 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 19 | - |
dc.citation.title | 한국임상약학회지 | - |
dc.citation.volume | 30 | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Vaccine | - |
dc.subject.keywordAuthor | safety | - |
dc.subject.keywordAuthor | adverse event following immunization | - |
dc.subject.keywordAuthor | human papilloma virus | - |
dc.subject.keywordAuthor | Brighton Collaboration | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.